U of T Spinoff Company Inks its Third Agreement
University of Toronto spinoff company Interface Biologics Inc. has announced the signing of an evaluation and exclusive license option agreement with Fresenius Medical Care, the world’s largest integrated provider of dialysis products and services. Under the agreement, Fresenius Medical Care will evaluate the use and efficacy of IBI’s EndexoTM technology to various components of Fresenius […]
Artery-on-a-Chip Studies Heart Disease
Professor Axel Guenther (MIE, IBBME) and colleagues have developed a microfluidic platform on which fragile blood vessels can be fixed, allowing the factors that promote and sustain cardiovascular diseases to be studied. Microvascular structure and function are currently studied using either an isometric approach, where small arteries are mounted on two wires, or an isobaric method, where […]
Assistant Professor Milica Radisic Named a “Scientist to Watch”
The prestigious life sciences magazine, The Scientist, recently named Assistant Professor Milica Radisic of the Institute of Biomaterials and Biomedical Engineering (IBBME) and the Department of Chemical Engineering & Applied Chemistry (ChemE) as the “Scientist to Watch” for her research involving engineered cardiac tissue called the “heart patch.” The idea for the heart patch first came to Radisic […]
Professors decode genetic messages with groundbreaking “Enigma machine” program
Brendan Frey from The Edward S. Rogers Sr. Department of Electrical and Computer Engineering and Benjamin Blencowe from the Donnelly Centre for Cellular and Biomolecular Research at the University of Toronto unveiled a groundbreaking “Enigma machine” program that can decode genetic messages. In a paper published on May 6 in the journal Nature entitled, “Deciphering the Splicing Code,” Frey and […]
